SEARCH

SEARCH BY CITATION

References

  • Bejarano, P.A., Noelken, M.E., Suzuki, K., Hudson, B.G. and Nagase, H. (1988) Degradation of basement membranes by human matrix metalloproteinase 3 (stromelysin). Biochem. J. 256, 413-419.
  • Black, S.J., Lunn, D.P., Yin, C., Hwang, M., Lenz, S.D. and Belknap, J.K. (2006) Leukocyte emigration in the early stages of laminitis. Vet. Immunol. Immunopathol. 109, 161-166.
  • Budak, M.T., Orsini, J.A., Pollitt, C.C. and Rubinstein, N.A. (2009) Gene expression in the lamellar dermis-epidermis during the developmental phase of carbohydrate overload-induced laminitis in the horse. Vet. Immunol. Immunopathol. 131, 86-96.
  • Chakraborti, S., Mandal, M., Das, S., Mandal, A. and Chakraborti, T. (2003) Regulation of matrix metalloproteinases: an overview. Mol. Cell. Biochem. 253, 269-285.
  • Clark, I.M., Swingler, T.E., Sampieri, C.L. and Edwards, D.R. (2008) The regulation of matrix metalloproteinases and their inhibitors. Int. J. Biochem. Cell Biol. 40, 1362-1378.
  • Clutterbuck, A.L., Harris, P., Allaway, D. and Mobasheri, A. (2008) Matrix metalloproteinases in inflammatory pathologies of the horse. Vet. J. 187, 27-38.
  • Cowland, J.B. and Borregaard, N. (1999) The individual regulation of granule protein mRNA levels during neutrophil maturation explains the heterogeneity of neutrophil granules. J. Leukoc. Biol. 66, 989-995.
  • Coyne, M.J., Cousin, H., Loftus, J.P., Johnson, P.J., Belknap, J.K., Gradil, C.M., Black, S.J. and Alfandari, D. (2009) Cloning and expression of ADAM-related metalloproteases in equine laminitis. Vet. Immunol. Immunopathol. 129, 231-241.
  • Crabbe, T., Smith, B., O'Connell, J. and Docherty, A. (1994) Human progelatinase A can be activated by matrilysin. FEBS Lett. 345, 14-16.
  • Croser, E. and Pollitt, C. (2006) Acute laminitis: Descriptive evaluation of serial hoof biopsies. Proc. Am. Ass equine Practnrs. 52, 542-546.
  • De la Rebiere de Pouyade, G., Riggs, L.M., Moore, J.N., Franck, T., Deby-Dupont, G., Hurley, D.J. and Serteyn, D. (2009) Equine neutrophil elastase in plasma, laminar tissue, and skin of horses administered black walnut heartwood extract. Vet. Immunol. Immunopathol. 135, 181-187.
  • Hernandez-Barrantes, S., Bernardo, M., Toth, M. and Fridman, R. (2002) Regulation of membrane type-matrix metalloproteinases. Semin. Cancer Biol. 12, 131-138.
  • Johnson, P.J., Tyagi, S.C., Katwa, L.C., Ganjam, V.K., Moore, L.A., Kreeger, J.M. and Messer, N.T. (1998) Activation of extracellular matrix metalloproteinases in equine laminitis. Vet. Rec. 142, 392-396.
  • Jones, G.C. and Riley, G.P. (2005) ADAMTS proteinases: A multi-domain, multi-functional family with roles in extracellular matrix turnover and arthritis. Arthritis Res. Ther. 7, 160-169.
  • Kashiwagi, M., Tortorella, M., Nagase, H. and Brew, K. (2001) TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5). J. Biol. Chem. 276, 12501-12504.
  • Kessenbrock, K., Plaks, V. and Werb, Z. (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141, 52-67.
  • Kyaw-Tanner, M. and Pollitt, C.C. (2004) Equine laminitis: increased transcription of matrix metalloproteinase-2 (MMP-2) occurs during the developmental phase. Equine vet. J. 36, 221-225.
  • Kyaw-Tanner, M.T., Wattle, O., van Eps, A.W. and Pollitt, C.C. (2008) Equine laminitis: Membrane type matrix metalloproteinase-1 (MMP-14) is involved in acute phase onset. Equine vet. J. 40, 482-487.
  • Lambert, E., Dasse, E., Haye, B. and Petitfrere, E. (2004) TIMPs as multifacial proteins. Crit. Rev. Oncol. Hematol. 49, 187-198.
  • Lauer-Fields, J.L., Minond, D., Sritharan, T., Kashiwagi, M., Nagase, H. and Fields, G.B. (2007) Substrate conformation modulates aggrecanase (ADAMTS-4) affinity and sequence specificity. Suggestion of a common topological specificity for functionally diverse proteases. J. Biol. Chem. 282, 142-150.
  • Livak, K.J. and Schmittgen, T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25, 402-408.
  • Loftus, J.P., Belknap, J.K. and Black, S.J. (2006) Matrix metalloproteinase-9 in laminae of black walnut extract treated horses correlates with neutrophil abundance. Vet. Immunol. Immunopathol. 113, 267-276.
  • Loftus, J., Johnson, P., Yin, C., Belknap, J. and Black, S. (2008) Matrix metalloproteinases and structural tissue damage in equine laminitis. In: American College of Veterinary Internal Medicine, San Antonio.
  • Loftus, J.P., Black, S.J., Pettigrew, A., Abrahamsen, E.J. and Belknap, J.K. (2007) Early laminar events involving endothelial activation in horses with black walnut- induced laminitis. Am. J. vet. Res. 68, 1205-1211.
  • Loftus, J.P., Johnson, P.J., Belknap, J.K., Pettigrew, A. and Black, S.J. (2009) Leukocyte-derived and endogenous matrix metalloproteinases in the lamellae of horses with naturally acquired and experimentally induced laminitis. Vet. Immunol. Immunopathol. 129, 221-230.
  • Milinovich, G.J., Trott, D.J., Burrell, P.C., Croser, E.L., Al Jassim, R.A., Morton, J.M., van Eps, A.W. and Pollitt, C.C. (2007) Fluorescence in situ hybridization analysis of hindgut bacteria associated with the development of equine laminitis. Environ. Microbiol. 9, 2090-2100.
  • Morrison, C.J., Butler, G.S., Bigg, H.F., Roberts, C.R., Soloway, P.D. and Overall, C.M. (2001) Cellular activation of MMP-2 (gelatinase A) by MT2-MMP occurs via a TIMP-2-independent pathway. J. Biol. Chem. 276, 47402-47410.
  • Mungall, B.A. and Pollitt, C.C. (1999) Zymographic analysis of equine laminitis. Histochem. Cell Biol. 112, 467-472.
  • Nakamura, H., Fujii, Y., Inoki, I., Sugimoto, K., Tanzawa, K., Matsuki, H., Miura, R., Yamaguchi, Y. and Okada, Y. (2000) Brevican is degraded by matrix metalloproteinases and aggrecanase-1 (ADAMTS4) at different sites. J. Biol. Chem. 275, 38885-38890.
  • Nie, J. and Pei, D. (2003) Direct activation of pro-matrix metalloproteinase-2 by leukolysin/membrane-type 6 matrix metalloproteinase/matrix metalloproteinase 25 at the asn(109)-Tyr bond. Cancer Res. 63, 6758-6762.
  • Noschka, E., Vandenplas, M.L., Hurley, D.J. and Moore, J.N. (2009) Temporal aspects of laminar gene expression during the developmental stages of equine laminitis. Vet. Immunol. Immunopathol. 129, 242-253.
  • Obel, N. (1948) Studies on the Histopathology of Acute Laminitis, Almqvist & Wiksells Boktryckeri AB, Stockholm.
  • Owen, C.A. (2008) Leukocyte cell surface proteinases: regulation of expression, functions, and mechanisms of surface localization. Int. J. Biochem. Cell Biol. 40, 1246-1272.
  • Pawlak, E., Wang, L., Alfandari, D., Johnson, P.J., Belknap, J.K. and Black, S.J. (2009) Localization and function of sulfated proteoglycans in the equine digital laminae. In: Proceedings of the Second AAEP Foundation Equine Laminitis Research Workshop, West Palm Beach.
  • Pirila, E., Sharabi, A., Salo, T., Quaranta, V., Tu, H., Heljasvaara, R., Koshikawa, N., Sorsa, T. and Maisi, P. (2003) Matrix metalloproteinases process the laminin-5 gamma 2-chain and regulate epithelial cell migration. Biochem. Biophys. Res. Commun. 303, 1012-1017.
  • Pollitt, C.C. (1996) Basement membrane pathology: A feature of acute equine laminitis. Equine vet J. 28, 38-46.
  • Pollitt, C.C. (2010) The anatomy and physiology of the suspensory apparatus of the distal phalanx. Vet. Clin. N. Am.: Equine Pract. 26, 29-49.
  • Pollitt, C.C. and Daradka, M. (1998) Equine laminitis basement membrane pathology: loss of type IV collagen, type VII collagen and laminin immunostaining. Equine vet. J., Suppl. 26, 139-144.
  • Pollitt, C.C., Pass, M.A. and Pollitt, S. (1998) Batimastat (BB-94) inhibits matrix metalloproteinases of equine laminitis. Equine vet. J., Suppl. 26, 119-124.
  • Sambrook, J., Fritsch, E. and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd edn., Cold Spring Harbour Laboratory Press, Cold Spring Harbor.
  • Sternlicht, M.D. and Werb, Z. (2001) How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17, 463-516.
  • Tortorella, M.D., Burn, T.C., Pratta, M.A., Abbaszade, I., Hollis, J.M., Liu, R., Rosenfeld, S.A., Copeland, R.A., Decicco, C.P., Wynn, R., Rockwell, A., Yang, F., Duke, J.L., Solomon, K., George, H., Bruckner, R., Nagase, H., Itoh, Y., Ellis, D.M., Ross, H., Wiswall, B.H., Murphy, K., Hillman, M.C., Jr, Hollis, G.F., Newton, R.C., Magolda, R.L., Trzaskos, J.M. and Arner, E.C. (1999) Purification and cloning of aggrecanase-1: A member of the ADAMTS family of proteins. Science 284, 1664-1666.
  • van Eps, A.W. and Pollitt, C.C. (2006) Equine laminitis induced with oligofructose. Equine vet. J. 38, 203-208.
  • Visse, R. and Nagase, H. (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry. Circ. Res. 92, 827-839.
  • Visser, M.B. (2009) Investigation of Proteolysis of the Basement Membrane during the Development of Equine Laminitis, The University of Queensland, Brisbane.
  • Visser, M.B. and Pollitt, C.C. (2011) The timeline of lamellar basement membrane changes during equine laminitis development. Equine vet. J. 43, 471-477.
  • Wang, J., Lelse, B., Gustafson, A., Nanduri, B., Belknap, J.K. and Chowdhary, B. (2009a) Genome-wide transcriptome profiling of laminar tissue during early stages of carbohydrate overload-induced equine laminitis. In: Proceedings of the Second AAEP Foundation Equine Laminitis Research Workshop, West Palm Beach.
  • Wang, L., Pawlak, E., Alfandari, D., Johnson, P.J., Belknap, J.K. and Black, S.J. (2009b) Gene and protein expression of polysulfated proteoglycan ECM components in the equine digital lamellae. In: Proceedings of the Second AAEP Foundation Equine Laminitis Research Workshop, West Palm Beach.
  • Wang, F.Q., So, J., Reierstad, S. and Fishman, D.A. (2005) Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase. Int. J. Cancer 114, 19-31.
  • Westling, J., Gottschall, P.E., Thompson, V.P., Cockburn, A., Perides, G., Zimmermann, D.R. and Sandy, J.D. (2004) ADAMTS4 (aggrecanase-1) cleaves human brain versican V2 at Glu405-Gln406 to generate glial hyaluronate binding protein. Biochem. J. 377, 787-795.
  • Zhao, H., Bernardo, M.M., Osenkowski, P., Sohail, A., Pei, D., Nagase, H., Kashiwagi, M., Soloway, P.D., DeClerck, Y.A. and Fridman, R. (2004) Differential inhibition of membrane type 3 (MT3)-matrix metalloproteinase (MMP) and MT1-MMP by tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-3 rgulates pro-MMP-2 activation. J. Biol. Chem. 279, 8592-8601.